Provided by Tiger Fintech (Singapore) Pte. Ltd.

Karyopharm Therapeutics

3.85
-0.2200-5.41%
Volume:151.97K
Turnover:613.20K
Market Cap:33.26M
PE:-0.31
High:4.17
Open:4.09
Low:3.85
Close:4.07
Loading ...

Karyopharm Therapeutics Is Maintained at Outperform by Baird

Dow Jones
·
03 Mar

Karyopharm Therapeutics Inc : Baird Cuts Target Price to $54 From $75

THOMSON REUTERS
·
28 Feb

Karyopharm Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Feb

Karyopharm Therapeutics Inc : H.c. Wainwright Adjusts Target Price to $56 From $7 to Reflect 1-for-15 Reverse Stock Split

THOMSON REUTERS
·
26 Feb

Karyopharm trading halted, news pending

TIPRANKS
·
26 Feb

Karyopharm Therapeutics to Implement 1-for-15 Reverse Stock Split

MT Newswires Live
·
25 Feb

Karyopharm Announces 1-for-15 Reverse Stock Split

THOMSON REUTERS
·
24 Feb

Karyopharm Announces 1-for-15 Reverse Stock Split

PR Newswire
·
24 Feb

Karyopharm Therapeutics: Hold Rating Maintained Amid Revenue Stagnation and Competitive Pressures

TIPRANKS
·
23 Feb

Karyopharm Therapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
20 Feb

Karyopharm Therapeutics: Strong Financial Performance and Strategic Developments Justify Buy Rating

TIPRANKS
·
20 Feb

Karyopharm Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
20 Feb

Barclays Sticks to Its Buy Rating for Karyopharm Therapeutics (KPTI)

TIPRANKS
·
20 Feb

Karyopharm Therapeutics Inc (KPTI) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

GuruFocus.com
·
20 Feb

Q4 2024 Karyopharm Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Feb

Karyopharm Therapeutics Faces Financial Uncertainty Amid $1.6 Billion Deficit and Urgent Need for Funding

TIPRANKS
·
20 Feb

Karyopharm Therapeutics (KPTI) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
20 Feb

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
19 Feb

Karyopharm Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
19 Feb

Karyopharm Therapeutics Q4 Net Income USD -30.78 Million

Reuters
·
19 Feb